title: Current Therapy of Acquired Ocular Toxoplasmosis: A Review.
abstract: Caused by the parasite Toxoplasma gondii, ocular toxoplasmosis (OT) is the most common form of posterior infectious uveitis. Combined antiparasitic therapy is the standard treatment for OT, but several other schemes have been proposed. The purpose of the present study was to review the literature on the treatment of OT and provide ophthalmologists with up-to-date information to help reduce OT-related visual morbidity. In conclusion, no ideal treatment scheme was identified; currently prescribed therapeutic schemes yield statistically similar functional outcomes.
authors.affiliation: 1 Specialized Medicine Department, Federal University of Espirito Santo , Vitória, Brazil .
authors.forename: Guilherme Sturzeneker Cerqueira
authors.initials: GS
authors.lastname: Lima
authors.affiliation: 2 Medicine Department, Empresa Brasileira de Ensino, Pesquisa e Extensão SA-Multivix , Vitória, Brazil .
authors.forename: Patricia Grativol Costa
authors.initials: PG
authors.lastname: Saraiva
authors.affiliation: 1 Specialized Medicine Department, Federal University of Espirito Santo , Vitória, Brazil .
authors.forename: Fábio Petersen
authors.initials: FP
authors.lastname: Saraiva
mesh_terms: D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D014122:Toxoplasma / Q000302:isolation & purification*; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy* / Q000469:parasitology
chemical_list: D000981:Antiprotozoal Agents